Omentin-1 vs Glucagon

Head-to-head comparison of Omentin-1 (Omentin-1 (Intelectin-1, ITLN1)) and Glucagon (Glucagon) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyOmentin-1Glucagon
CategoryDiabetes & MetabolicDiabetes & Metabolic
Full NameOmentin-1 (Intelectin-1, ITLN1)Glucagon
Molecular Weight~35 kDa3482.75
Half-Lifehours5-10 min
Amino Acids31329
Typical DoseNo approved human dose; research use only1 mg IM/SC for severe hypoglycemia or 3 mg intranasal
RouteIV|SCIM|SC|IN|IV
Purity≥98%≥98%
Studies Count8293
Research StatusPre-clinicalApproved

Omentin-1 Benefits

  • insulin sensitivity
  • glucose uptake
  • lipid handling

Glucagon Benefits

  • rapid hypoglycemia reversal
  • raises plasma glucose
  • useful in emergency rescue

Omentin-1 Dosing

not established|not established

Glucagon Dosing

1 mg IM/SC|3 mg intranasal

Omentin-1 Side Effects

  • unknown
  • immunogenicity risk

Glucagon Side Effects

  • nausea
  • vomiting

Research Overview

Omentin-1

Lower omentin-1 levels are often associated with obesity, insulin resistance, and metabolic syndrome. Research continues on its use as a biomarker and as a mechanistic lead for AMPK-linked metabolic interventions.

Glucagon

Clinical and emergency medicine use is well established for severe hypoglycemia, with newer stable formulations improving ease of administration.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Omentin-1 stacks with:

Intelectin-1ITLN1

Glucagon stacks with:

glucagonGlucaGenBaqsimiGvoke
AMPKadipokineinsulin-sensitizingbiomarkerdiabetesmetabolicrescueglucose-regulation